Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Albemarle

Albemarle Stock In Focus as Citi Issues Bullish Note on Lithium Stocks

Albemarle stock is in focus as Citi issues a bullish note on the lithium sector. Here’s why the firm expects ALB shares to rally further in 2026.

Barchart

Are Wall Street Analysts Bullish on Albemarle Corporation Stock?

Albemarle Corporation has rallied the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

Barchart

Albemarle’s Quarterly Earnings Preview: What You Need to Know

Albemarle is set to report its Q1 results next month, and analysts are projecting its EPS will climb in triple-digits.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Albemarle Stock: Is ALB Outperforming the Materials Sector?

Albemarle has outperformed its sector peers recently, and analysts remain moderately optimistic about the stock’s prospects.

Barchart

Gold and Silver Rebound, But This Metal Is Outperforming Both

Driven by a multitude of industrial applications, lithium is outperforming precious metals this year. Investors can use three ETFs to gain exposure.

MarketBeat

Is Albemarle Setting Up for a Lithium-Fueled Rebound?

Albemarle stock dipped after earnings, but rising lithium demand, particularly from AI-driven power needs could create a compelling long-term entry point

MarketBeat

What Are Wall Street Analysts' Target Price for Albemarle Stock?

As Albemarle has notably outpaced the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Albemarle’s Q4 2025 Earnings: What to Expect

Albemarle is set to report its Q4 results. Here’s what analysts are expecting prior to that from this outperforming stock.

Barchart

Albemarle Sits at the Center of Lithium’s Next Cycle

Albemarle stock surged in 2025, but analysts see further upside. Rising lithium prices, storage demand, and disciplined supply could shape ALB in 2026

MarketBeat

This ETF Is Up 146% as the Battle Over Rare Earths Heats Up

After being labeled a national security priority by the Trump administration, rare earths surged. That’s likely to continue this year amid ongoing tailwinds.

MarketBeat

Is Albemarle Stock Outperforming the Dow?

Albemarle stock continues to run ahead of the Dow, supported by largely favorable analyst views.

Barchart

Albemarle Stock: Is Wall Street Bullish or Bearish?

Specialty chemical giant Albemarle has underperformed the broader market over the past year, and analysts remain cautious about the stock’s prospects.

Barchart

3 Signals Pointing to a Turnaround for Albemarle

Albemarle is strengthening its balance sheet with an asset sale as a wave of analyst upgrades suggests a potential recovery for the lithium leader.

MarketBeat

Stock Of The Day: Trading Opportunities In Albemarle?

Albemarle Corporation (NYSE:ALB) is trading lower on Monday. The shares were up on Friday but, at last check on Monday, were down over 6.3%. This move followed positive comments and a new ‘buy' recommendation from a brokerage firm.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Albemarle Nets $660 Million From Asset Sales, Keeps Foot In Ketjen's Future

Albemarle Corporation (NYSE:ALB), a supplier of materials used in mobility, energy, connectivity, and health applications, has entered into a definitive agreement to sell a controlling interest in Ketjen Corporation’s refining catalyst solutions business to KPS Capital Partners, LP.

Benzinga

This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Barchart

Albemarle Earnings Preview: What to Expect

Albemarle is prepared to release its third-quarter results next month, with analysts predicting a significant double-digit earnings rise.

MarketBeat

5 Surprising Stocks Set to Benefit From a Future Robotics Boom

The robotics revolution is accelerating in 2025, expanding beyond factories into healthcare, logistics, and homes, fueled by advances in AI and automation.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Stock Of The Day: Reversal Time For Albemarle?

Trading in Albemarle Corporation (NYSE:ALB) is quiet Friday. The stock has stalled at a resistance level.

MarketBeat

5 EV Battery and Lithium Stocks Charging the Future

The EV battery market is projected to exceed $250 billion by 2035, presenting investors with opportunities in both lithium giants and high-risk innovators.

MarketBeat

Lithium Americas Rally Lifts Other Rare Earth Stocks

Lithium Americas (LAC) surged 90% after a U.S. government stake fueled rare earth momentum, putting Albemarle (ALB) and Uranium Energy (UEC) on watch.

Benzinga

Abermarle Shares Are Trading Higher Wednesday: What's Going On?

Shares of Albemarle Corporation (NYSE:ALB) are trading higher Wednesday alongside several other lithium stocks after Lithium Americas Corp. (NYSE:LAC) surged on reports that the Trump administration is seeking an equity stake in the company.

Barchart

Is Albemarle Stock Underperforming the Nasdaq?

Albemarle has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.

MarketBeat

Chinese Lithium Production Halt Means Upside for These 3 Stocks

New data center buildouts and lower Chinese lithium production have sent prices soaring in July 2025, creating upside in these 3 stocks.

Benzinga

Jim Cramer: This Real Estate Stock Is 'Still Too Expensive'

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Equinix, Inc. (NASDAQ:EQIX) is “still too expensive.”

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.